What is the state of the biosciences industry in Colorado and nationwide? Polsinelli Shughart Life Sciences Chair Kevin Sweeney was invited to speak at Biosciences Day at the Capitol in Colorado in February 2011. The firm was a sponsor of the event.
To hear a portion of Sweeney's remarks, click here
About Kevin Sweeney
Kevin Sweeney is Chair of Polsinelli Shughart's multidisciplinary Life Sciences practice group and a senior member of its Corporate Finance group. He has more than 25 years experience in handling mergers and acquisitions, public and private securities offerings, venture capital financing, technology transfer, and other complex financial and strategic transactions for clients in a wide variety of industries, with a special emphasis in serving as a strategic advisor to the top management of life science companies of all types and stages of development. He is a strategic partner to many emerging and growth companies, assisting in the development and implementation of their business, financial and legal goals.
Mr. Sweeney uses his broad contacts in the national scientific, academic, business and financial communities to assist companies, universities, and other scientific organizations in achieving their business and financial goals. His understanding and appreciation of the scientific and humanitarian mission of these entities was fostered by early work for entities such as Marion Laboratories, BioTechnica International, and AVAX Technologies and continues with numerous emerging, growth, and established entities that advance human health, animal health, plant science, "green" and industrial technologies, and biosafety and homeland security sciences, as well as computer and software technologies. One of most exciting endeavors of Mr. Sweeney’s career was the opportunity to work with Nobel Laureate Dr. Sydney Brenner to co-found the Molecular Sciences Institute in Berkeley, California, as one of the leading multidisciplinary basic scientific institutes focused on predictive biology.